Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CATVOTCMKTS:FFNTFOTCMKTS:GNHAFOTCMKTS:TGIFF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCATV4Cable TV International$0.00$0.00$0.00▼$0.00N/AN/A42.10 million shs17.92 million shsFFNTF4Front Ventures$0.00+60.0%$0.00$0.00▼$0.11N/AN/A1.47 million shs74,732 shsGNHAFVifor Pharma$181.25$181.25$174.25▼$183.50N/AN/A100 shsN/ATGIFF1933 Industries$0.00+2.2%$0.00$0.00▼$0.01N/AN/A136,907 shs30,157 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCATV4Cable TV International0.00%0.00%0.00%0.00%-76.00%FFNTF4Front Ventures0.00%+700.00%+433.33%-81.82%-97.95%GNHAFVifor Pharma0.00%0.00%0.00%0.00%0.00%TGIFF1933 Industries0.00%-14.55%+4.44%+38.24%-50.53%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCATV4Cable TV InternationalN/AN/AN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/AN/AN/AGNHAFVifor PharmaN/AN/AN/AN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCATV4Cable TV International 0.00N/AN/AN/AFFNTF4Front Ventures 0.00N/AN/AN/AGNHAFVifor Pharma 0.00N/AN/AN/ATGIFF1933 Industries 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCATV4Cable TV InternationalN/AN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AN/AGNHAFVifor PharmaN/AN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCATV4Cable TV InternationalN/A-$0.01N/A∞N/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/A0.00∞N/AN/AN/AN/AN/AGNHAFVifor PharmaN/AN/A0.00∞N/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCATV4Cable TV InternationalN/AN/AN/AN/AN/AFFNTF4Front VenturesN/AN/AN/AN/AN/AGNHAFVifor PharmaN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCATV4Cable TV InternationalN/AFFNTF4Front VenturesN/AGNHAFVifor PharmaN/ATGIFF1933 IndustriesN/AInsider OwnershipCompanyInsider OwnershipCATV4Cable TV InternationalN/AFFNTF4Front VenturesN/AGNHAFVifor PharmaN/ATGIFF1933 IndustriesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCATV4Cable TV International10N/AN/ANot OptionableFFNTF4Front Ventures460N/AN/ANot OptionableGNHAFVifor Pharma2,200N/AN/ANot OptionableTGIFF1933 Industries87N/AN/ANot OptionableGNHAF, TGIFF, CATV, and FFNTF HeadlinesRecent News About These Companies1933 Industries Reports Profit in Q3 2025 Amidst Industry ChallengesJune 16, 2025 | tipranks.com1933 Industries Reports Profit in Third Quarter 2025 Financial ResultsJune 16, 2025 | accessnewswire.comA1933 Industries Completes Full Acquisition of AMA SubsidiaryJune 2, 2025 | tipranks.com1933 Industries Announces the Completion of the Purchase of 9% Interest of Cultivation and Production SubsidiaryJune 2, 2025 | accessnewswire.comA1933 Industries Completes Acquisition of Remaining Interest in SubsidiaryMay 22, 2025 | tipranks.com1933 Industries To Complete Purchase of 9% Interest of Cultivation and Production SubsidiaryMay 22, 2025 | accessnewswire.comA1933 Industries Stock Short Interest Report | OTC:TGIFF | BenzingaApril 21, 2025 | benzinga.com1933 sees uptick in revenue in NevadaApril 2, 2025 | greenmarketreport.comG1933 Industries Reports Second Quarter 2025 Financial ResultsMarch 31, 2025 | accessnewswire.comACSE Bulletin: Reinstatement - 1933 Industries Inc. (TGIF)March 6, 2025 | newsfilecorp.comN1933 Industries Inc.: 1933 Industries Announces First Quarter 2025 Financial ReportFebruary 28, 2025 | finanznachrichten.de1933 Industries Announces First Quarter 2025 Financial ReportFebruary 27, 2025 | accessnewswire.comA1933 Industries Inc.: 1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 MillionFebruary 27, 2025 | finanznachrichten.de1933 Industries losses contract year-over-year, but company still in the redFebruary 26, 2025 | greenmarketreport.comG1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 MillionFebruary 25, 2025 | accessnewswire.comA1933 Industries Appoints New CFO and VP FinanceJanuary 31, 2025 | accessnewswire.comA1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly ReportJanuary 24, 2025 | accessnewswire.comA1933 Industries Inc.: 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management ChangesJanuary 11, 2025 | finanznachrichten.de1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management ChangesJanuary 11, 2025 | markets.businessinsider.com1933 Industries Inc.: 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly ReportDecember 27, 2024 | finanznachrichten.deGNHAF, TGIFF, CATV, and FFNTF Company Descriptions4Cable TV International OTCMKTS:CATV$0.0003 0.00 (0.00%) As of 07/3/2025 12:39 PM Eastern4Cable TV International, Inc. provides specialty solutions to the cable television sector. It offers a suite of products comprising RF to Fiber (RF2F), a proprietary line of coax-to-fiber taps that enables cable operators to reach homes within their franchise authorized area; PowerMiser, a circuitry, which allows a low current 1 GHz amplifier and/or line extender to be constructed with a decrease in current power requirements; RF over Glass (RFoG) signal distribution technology that combines the existing cable TV infrastructure with fiber optics to reach the home; and Node+0 application, which combines the RFoG technology platform with its PowerMiser engineering to take fiber signal. The company also provides SOLAR-CATV that utilizes solar power and helps the operator extend service to areas not presently served without adding power sources; and Dynamically Scalable Return technology, which allows nodes, R-ONU's (RFoG optical network units) to adjust their return bandwidth by changing the channel lineup at the head end, as well as repair, testing, and upgrade services. It markets and sells its products through a network of dealers in the United States and Canada primarily to independent cable TV operators, as well as to multiple system operators. 4Cable TV International, Inc. was incorporated in 2007 and is based in Conway, South Carolina.4Front Ventures OTCMKTS:FFNTF$0.0016 +0.00 (+60.00%) As of 07/3/2025 11:42 AM Eastern4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.Vifor Pharma OTCMKTS:GNHAF$181.25 0.00 (0.00%) As of 10/21/2022Vifor Pharma AG, a pharmaceutical company, focuses on the development, manufacture, and commercialization of pharmaceutical products in Switzerland, rest of Europe, the United States, and internationally. The company offers Ferinject/Injectafer, a solution of ferric carboxymaltose used for the treatment of iron deficiency and iron deficiency anemia; Maltofer, an oral iron polymaltose complex for infants, children, adolescents, and pregnant woman with iron deficiency; and Mircera, a long-acting erythropoiesis-stimulating agent (ESA) to treat symptomatic anemia associated with the chronic kidney disease (CKD).It also provides Retacrit, a short-acting ESA; Venofer, an intravenous iron sucrose used in the intravenous treatment of iron deficiency; and Velphoro, a non-calcium, iron-based chewable phosphate binder for the treatment of hyperphosphatemia in adults with CKD undergoing dialysis. In addition, the company offers Rayaldee, an orally administered, extended release formulation of calcifediol for the treatment of secondary hyperparathyroidism in patients with CKD; and Veltassa for the treatment of hyperkalemia in CKD and chronic heart failure patients. Further, it develops Vadadustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of altitude on oxygen availability; Avacopan, an orally-administered, highly selective inhibitor of C5aR1 for the treatment of orphan and rare renal diseases;ANG-3777 for the treatment of transplant-associated acute kidney injury; Difelikefalin for the treatment for chronic kidney disease-associated pruritus; and VIT-2763 to treat beta-thalassemia. Vifor Pharma AG has a strategic partnership with Fresenius Kabi and Zeria Pharmaceutical. The company was founded in 1872 and is headquartered in Sankt Gallen, Switzerland. As of August 9, 2022, Vifor Pharma AG operates as a subsidiary of CSL Behring AG.1933 Industries OTCMKTS:TGIFF$0.0047 +0.00 (+2.17%) As of 07/3/2025 11:26 AM Eastern1933 Industries Inc., together with its subsidiaries, engages in the cultivation and production of cannabis products in the United States. It operates in three segments: the Medical Segment, the Recreational Segment, and the CBD-Infused Products Segment. The company produces, packages, and markets cannabidiol (CBD)-infused products, including tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brand names. It also offers craft-style cannabis, infused pre-rolls, full spectrum oils, distillates, terpenes, and vaporizer products; and boutique concentrates, such as shatters, crumbles, batters, sugar waxes, diamonds, and cured and live resins under the AMA and Level X brand names. The company offers its products through retail dispensaries and retail outlets, as well as through its e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
